⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16020173 | 0.91 | — | — | |
| SCHEMBL14698731 | 0.73 | HTR6 (0.31) | — | |
| SCHEMBL414164 | 0.68 | ELANE (0.42) | — | |
| SCHEMBL15025087 | 0.66 | PDGFRA (0.35) | — | |
| SCHEMBL1077028 | 0.63 | HTR6 (0.35) | — | |
| SCHEMBL21773182 | 0.62 | ALDH1A1 (0.37) | — | |
| SCHEMBL29830999 | 0.62 | GPR3 (0.33) | — | |
| SCHEMBL18233837 | 0.61 | HTR2C (0.33) | — | |
| SCHEMBL517159 | 0.60 | ALDH1A1 (0.38) | — | |
| SCHEMBL517770 | 0.60 | HTR6 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9079902-B2 | Heteroaryl sodium channel inhibitors | AMGEN INC. (US) | 2015-07-14 | — | — | US | disclosed |
| US-20140256707-A1 | Heteroaryl Sodium Channel Inhibitors | AMGEN INC. (US) | 2014-09-11 | — | — | US | disclosed |
| EP-2744805-A1 | HETEROARYL SODIUM CHANNEL INHIBITORS | Amgen Inc. (US) | 2014-06-25 | — | — | EP | disclosed |
| WO-2013025883-A1 | HETEROARYL SODIUM CHANNEL INHIBITORS | AMGEN INC. (US) | 2013-02-21 | — | — | WO | disclosed |